+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
Global Multiple Myeloma Drugs Market 2023-2027 - Product Thumbnail Image

Global Multiple Myeloma Drugs Market 2023-2027

  • Report
  • October 2022
  • 120 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Plaque Psoriasis - Pipeline Insight, 2024 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 240 Pages
  • Global
From
From
From
From
From
Biosimilar Growth Hormones Global Market Report 2024 - Product Thumbnail Image

Biosimilar Growth Hormones Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Insulin biosimilars Global Market Report 2024 - Product Thumbnail Image

Insulin biosimilars Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Filgrastim Biosimilars Global Market Report 2024 - Product Thumbnail Image

Filgrastim Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
From
From
From
Monoclonal Antibody Discovery and Analysis Market Report 2022-2032 - Product Thumbnail Image

Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

  • Report
  • December 2022
  • 437 Pages
  • Global
From
Loading Indicator